464 related articles for article (PubMed ID: 12410401)
1. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
Mochizuki A; Komatsuzaki Y; Shoji S
Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
[TBL] [Abstract][Full Text] [Related]
2. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
5. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
6. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
[TBL] [Abstract][Full Text] [Related]
8. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
9. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
[TBL] [Abstract][Full Text] [Related]
10. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
Piao YS; Wakabayashi K; Hayashi S; Yoshimoto M; Takahashi H
Clin Neuropathol; 2000; 19(4):163-9. PubMed ID: 10919347
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
Wang Y; Lü C; Ye Z
Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
[TBL] [Abstract][Full Text] [Related]
12. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
13. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
14. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
15. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
17. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
18. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.
Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H
Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein binding to rab3a in multiple system atrophy.
Dalfó E; Ferrer I
Neurosci Lett; 2005 May 20-27; 380(1-2):170-5. PubMed ID: 15854772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
